Codominance of cisplatin resistance in s
β
Yu-Lan Mary Ying; Ding-Wu Shen; Xing-Jie Liang; Michael M. Gottesman
π
Article
π
2003
π
John Wiley and Sons
π
English
β 138 KB
## Abstract Intrinsic or acquired resistance to cisplatin in cancer cells remains a major obstacle to successful chemotherapy. The clinically relevant genetic and molecular mechanisms of resistance have not yet been identified. Cisplatinβresistant (CPβr) human KB epidermoid carcinoma cell lines (He